Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- National Institutes of Health (2)
- Patent applications (2)
- Patent law (2)
- Public domain (2)
- Public policy (2)
-
- Research and development (2)
- Technology transfers (2)
- Authority (1)
- Bayh-Dole Act (1)
- Commercial policy (1)
- Competence (1)
- Corporations (1)
- DNA sequences (1)
- European Community (1)
- Exclusivity (1)
- External powers (1)
- Federal agencies (1)
- Funding (1)
- Human Genome Project (1)
- Incentives (1)
- Patent system (1)
- Scientific research (1)
- Sponsored research (1)
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Law
Intellectual Property And The External Power Of The European Community: The New Extension, A. David Demiray
Intellectual Property And The External Power Of The European Community: The New Extension, A. David Demiray
Michigan Journal of International Law
"[T]heory is somewhat lagging behind the facts and developing only in reaction to these facts," argues C.W.A. Timmermans regarding the European Community's (the EC or the Community) legal basis for extending its external power. The Community tends to extend its external competence before having a clear authority for doing so and only later provides a post hoc rationale. This observation suggests that the justification, not the propriety, of a newly acquired external competence is the question. Nowhere is this modus operandi better illustrated, or more sorely tested, than by the Community's growing involvement with and pursuit of international intellectual property …
Limiting The Role Of Patents In Technology Transfer, Rebecca S. Eisenberg
Limiting The Role Of Patents In Technology Transfer, Rebecca S. Eisenberg
Other Publications
Federal policy since 1980 has reflected an increasingly confident presumption that patenting discoveries made in the course of government-sponsored research is the most effective way to promote technology transfer and commercial development of those discoveries in the private sector. Policymakers in the past may have thought that the best way to achieve widespread use of government-sponsored research was to make the results freely available to the public; the new pro-patent policy stresses the need for exclusive rights as an incentive for industry to invest in bringing new products to market.
A Technology Policy Perspective On The Nih Gene Patenting Controversy, Rebecca S. Eisenberg
A Technology Policy Perspective On The Nih Gene Patenting Controversy, Rebecca S. Eisenberg
Articles
This article will use the NIH patent controversy as a focal point for considering when the results of government-sponsored research should be patented and when they should be dedicated to the public domain. First, this article will review the recent history of federal government policy on patenting the results of government-sponsored research. Next, this article will highlight some of the complexities involved in achieving technology transfer from the public sector to the private sector that current policy may oversimplify. With this background, this article will return to a more detailed analysis of the NIH cDNA patenting controversy and consider the …